Table 2a.
Clinicopathologic findings of clear cell renal cell carcinomas based on each subgroup in the first cohort
| Subgroup 1 (%) | Subgroup 2 (%) | P | |
|---|---|---|---|
| Total | 13 | 17 | |
| Sex | |||
| Men | 8 (61.5) | 12 (70.6) | .7055 |
| Women | 5 (38.5) | 5 (29.4) | |
| Age, y, range (median) | 32‐80 (66) | 49‐80 (68) | .6434 |
| Size, mm, range (median) | 22‐78 (35) | 18‐85 (52) | .1394 |
| Locus | |||
| Right | 5 (38.5) | 11 (64.7) | .2685 |
| Left | 8 (61.5) | 6 (35.3) | |
| Fuhrman grade | |||
| Grade 2 | 12 (92.3) | 10 (58.8) | .0924 |
| Grade 3 | 1 (7.7) | 7 (41.2) | |
| Necrosis | |||
| Present | 1 (7.7) | 5 (29.4) | .1961 |
| Absent | 12 (92.3) | 12 (70.6) | |
| Venous invasion | |||
| Positive | 1 (7.7) | 1 (5.9) | 1.0000 |
| Negative | 12 (92.3) | 16 (94.1) | |
| pT stage | |||
| pT1 | 11 (84.6) | 13 (76.4) | .8584 |
| pT2 | 1 (7.7) | 2 (11.8) | |
| pT3 | 1 (7.7) | 2 (11.8) | |
| Metachronous metastasis | |||
| Positive | 1 (7.7) | 10 (58.8) | .0067 |
| Negative | 12 (92.3) | 7 (41.2) | |
| Survival | |||
| Dead | 2 (15.4) | 5 (29.4) | .4268 |
| Alive | 11 (84.6) | 12 (70.6) | |